Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 17203973
Vasilescu J, et al. (2007) The proteomic reactor facilitates the analysis of affinity-purified proteins by mass spectrometry: application for identifying ubiquitinated proteins in human cells. J Proteome Res 6, 298-305 17203973
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

K334-ub - 5-HT(1A) (human)
Modsite: RNAEAKRkMALARER SwissProt Entrez-Gene
Orthologous residues
5‑HT(1A) (human): K334‑ub, 5‑HT(1A) (mouse): K334‑ub, 5‑HT(1A) (rat): K334‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K402-ub - ASH1L (human)
Modsite: SAMGLVNkDIGkKLM SwissProt Entrez-Gene
Orthologous residues
ASH1L (human): K402‑ub, ASH1L iso2 (human): K402‑ub, ASH1L (mouse): K400‑ub, ASH1L (rat): K400‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K406-ub - ASH1L (human)
Modsite: LVNkDIGkKLMSCPL SwissProt Entrez-Gene
Orthologous residues
ASH1L (human): K406‑ub, ASH1L iso2 (human): K406‑ub, ASH1L (mouse): K404‑ub, ASH1L (rat): K404‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K46-ub - ATAD1 (human)
Modsite: DAIDPTRkQKVEAQk SwissProt Entrez-Gene
Orthologous residues
ATAD1 (human): K46‑ub, ATAD1 (mouse): K46‑ub, ATAD1 (rat): K46‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K96-ub - ATRIP (human)
Modsite: RLLDGMSkNPSGKNR SwissProt Entrez-Gene
Orthologous residues
ATRIP (human): K96‑ub, ATRIP iso2 (human): K96‑ub, ATRIP (mouse): N96‑ub, ATRIP (rat): N96‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K816-ub - BAT2L iso5 (human)
Modsite: LPEAsSKkAEKEAKL SwissProt Entrez-Gene
Orthologous residues
BAT2L (human): K1510‑ub, BAT2L iso5 (human): K816‑ub, BAT2L (mouse): K827‑ub, BAT2L iso3 (mouse): K1514‑ub, BAT2L (rat): K1359‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary), NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K535-ub - CBFA2T3 (human)
Modsite: ERALAEAkRQAsEDA SwissProt Entrez-Gene
Orthologous residues
CBFA2T3 (human): K535‑ub, CBFA2T3 (mouse): K512‑ub, CBFA2T3 (rat): K511‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K295-ub - CCDC138 (human)
Modsite: EASEENRkIDIQAkR SwissProt Entrez-Gene
Orthologous residues
CCDC138 (human): K295‑ub, CCDC138 iso2 (human): K295‑ub, CCDC138 (mouse): K311‑ub, CCDC138 (rat): K312‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary), NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K225-ub - FAM76B iso2 (human)
Modsite: KKPKLESkPSNGDRS SwissProt Entrez-Gene
Orthologous residues
FAM76B (human): K225‑ub, FAM76B iso2 (human): K225‑ub, FAM76B (mouse): K225‑ub, FAM76B (rat): K225‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K113-ub - Fos (human)
Modsite: YSRAGVVktMtGGRA SwissProt Entrez-Gene
Orthologous residues
Fos (human): K113‑ub, Fos (mouse): K113‑ub, Fos (rat): K113‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K102-ub - GUF1 (human)
Modsite: IDKTKNNkQVLDKLQ SwissProt Entrez-Gene
Orthologous residues
GUF1 (human): K102‑ub, GUF1 (mouse): K84‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary)
Cellular systems studied:  cell lines
Species studied:  human

K191-ub - HOXB7 (human)
Modsite: WFQNRRMkWkKENKT SwissProt Entrez-Gene
Orthologous residues
HOXB7 (human): K191‑ub, HOXB7 (mouse): K191‑ub, HOXB7 (rat): K191‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary)
Cellular systems studied:  cell lines
Species studied:  human

K193-ub - HOXB7 (human)
Modsite: QNRRMkWkKENKTAG SwissProt Entrez-Gene
Orthologous residues
HOXB7 (human): K193‑ub, HOXB7 (mouse): K193‑ub, HOXB7 (rat): K193‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary)
Cellular systems studied:  cell lines
Species studied:  human

K483-ub - HUNK (human)
Modsite: QNTKALLkDRKASKS SwissProt Entrez-Gene
Orthologous residues
HUNK (human): K483‑ub, HUNK (mouse): K483‑ub, HUNK (rat): K483‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K275-ub - KIF14 (human)
Modsite: NKFGsLEkRtPTKCT SwissProt Entrez-Gene
Orthologous residues
KIF14 (human): K275‑ub, KIF14 (mouse): T260‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary)
Cellular systems studied:  cell lines
Species studied:  human

K685-ub - KIF16B iso5 (human)
Modsite: KFEEERLkDLVQQKD SwissProt Entrez-Gene
Orthologous residues
KIF16B (human): K841‑ub, KIF16B iso2 (human): K841‑ub, KIF16B iso5 (human): K685‑ub, KIF16B (mouse): K841‑ub, KIF16B iso2 (mouse): K438‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary), NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K216-ub - MLL (human)
Modsite: KIKKKDSkSIEkkRG SwissProt Entrez-Gene
Orthologous residues
MLL (human): K216‑ub, MLL iso2 (human): K216‑ub, MLL iso3 (human): K216‑ub, MLL (mouse): K214‑ub, MLL iso5 (mouse): K247‑ub, MLL (rat):
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary)
Cellular systems studied:  cell lines
Species studied:  human

K220-ub - MLL (human)
Modsite: KDSkSIEkkRGRPPT SwissProt Entrez-Gene
Orthologous residues
MLL (human): K220‑ub, MLL iso2 (human): K220‑ub, MLL iso3 (human): K220‑ub, MLL (mouse): K218‑ub, MLL iso5 (mouse): K251‑ub, MLL (rat):
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary)
Cellular systems studied:  cell lines
Species studied:  human

K221-ub - MLL (human)
Modsite: DSkSIEkkRGRPPTF SwissProt Entrez-Gene
Orthologous residues
MLL (human): K221‑ub, MLL iso2 (human): K221‑ub, MLL iso3 (human): K221‑ub, MLL (mouse): K219‑ub, MLL iso5 (mouse): K252‑ub, MLL (rat):
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary)
Cellular systems studied:  cell lines
Species studied:  human

K222-ub - TARS (human)
Modsite: AFERLEVkkETLLAM SwissProt Entrez-Gene
Orthologous residues
TARS (human): K222‑ub, TARS iso2 (human): K255‑ub, TARS (mouse): K221‑ub, TARS (rat): K194‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease

K267-ub - TRAF3IP3 (human)
Modsite: ysPWGMKkVLLEMED SwissProt Entrez-Gene
Orthologous residues
TRAF3IP3 (human): K267‑ub, TRAF3IP3 (mouse): K268‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary)
Cellular systems studied:  cell lines
Species studied:  human

K48-ub - ubiquitin (human)
Modsite: QRLIFAGkQLEDGRT SwissProt
Orthologous residues
ubiquitin (human): K48‑ub, ubiquitin (mouse): K48‑ub, ubiquitin (rat): K48‑ub, ubiquitin (cow): K48‑ub
Characterization
Methods used to characterize site in vivo mass spectrometry
Relevant cell lines - cell types - tissues:  NCI-H1299 (pulmonary), NCI-H1299 (pulmonary) [VCP (human), transfection, VCP siRNA construct was used to transfect cells]
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
siRNA increase VCP siRNA
VCP (human) decrease